InvestorsHub Logo
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 03/02/2021 8:24:36 AM

Tuesday, March 02, 2021 8:24:36 AM

Post# of 27624
CERC - 3.73 Pre-market at 4.10/4.17

Cerecor Announces Final Efficacy Data From Phase 2 Trial Of CERC-002; Says CERC-002 Was Statistically Significant In Reducing Respiratory Failure And Mortality At Day 28 In Patients Hospitalized With COVID-19 Associated Pneumonia

https://stockcharts.com/h-sc/ui?s=cerc
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.